Natasa Rajicic has enjoyed being a biostatistician for over 20 years. She is currently a Senior Director of Strategic Consulting at Cytel Inc., a leading global provider of innovative analytical software and services to the life sciences industry. At Cytel, Rajicic helps clients address difficult questions around study designs and overall drug development. Prior to joining Cytel, Rajicic worked as a biostatistician at Pfizer, New York for 11 years, where she left as a Director, Statistics Group Lead for endocrine care statistics.
Earlier in her career, Rajicic spent 5 years at the Center for Biostatistics in AIDS Research at Harvard School of Public Health in Boston. She also worked as a consulting biostatistician at the Massachusetts General Hospital Biostatistics Unit where she did her doctoral research in survival analysis of longitudinal microarray data. Natasa is an author on over 30 scientific publications.
Rajicic received a B.A. in Mathematics and a MS in Statistics from West Virginia University, and a doctorate degree in Biostatistics from Harvard School of Public Health.
After 12 years of enjoying the New York City, Rajicic moved to the Columbia River Gorge in the Pacific Northwest where she lives with her cat and a husband.